RESEARCH PAPER
The quality of life of farmers with chronic obstructive pulmonary disease (COPD)
 
More details
Hide details
1
Department of Applied Psychology, Medical University of Lublin, Poland
2
Chair and Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Poland
3
Department of Oncology, Medical University of Lublin, Poland
4
Department of Diagnostic and Minisurgery of Glaucoma, Mesical University of Lublin, Poland
5
Department of Health Psychology, Jagiellonian University Medical College, Cracow, Poland
 
Ann Agric Environ Med 2017;24(2):283–287
KEYWORDS:
ABSTRACT:
Introduction and objective:
COPD is a medical state characterized by chronically poor airflow, and typically worsens over time. Farmers have an increased risk of COPD because of being exposed to ammonia, hydrogen sulfide, inorganic dust, and organic dust. The quality of life of the ill depends on biomedical as well as psychosocial factors, the impact of which has not been a frequent subject of studies among COPD patients. The aim of the study was to indicate the factors that have negative and positive influence on the quality of life of farmers suffering from COPD.

Material and Methods:
The study was conducted among 84 farmers treated for COPD in the Department of Pneumology, Oncology and Allergology of the Medical University in Lublin, Poland. The differences between the farmers concerned: severity of the disease, level of education and income, frequency of smoking tobacco and drinking alcohol, kinds of support they receive from their families, and the level of depression and anxiety experienced by the patients.

Results:
The study revealed that most patients suffered from depressive and anxiety disorders, and the level of depression higher among the patients who smoked more. Lack of family support had significant influence on exacerbation of the patient’s depressive and anxiety symptoms. Patients who had recently experienced a critical situation presented with more severe COPD symptoms, lower quality of life and a higher level of depression. Higher income of the patients had positive influence on their quality of life. Farmers addicted to alcohol suffered from a higher level of anxiety.

CORRESPONDING AUTHOR:
Joanna Milanowska   
Department of Applied Psychology, Medical University of Lublin, Poland
 
REFERENCES (46):
1. Stelmach A, Wanot B, Biskupek-Wanot A. Chromic Obstructive Pulmonary disease (COPD) – an underestimated problem. PNAP. 2016; 17(2): 69–79.
2. Pauwels RA, Buist AS, Ma P. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001; 46: 798–825.
3. Lopez AD, Shibuya K, Rao C et.al. Chronic obsturative pulmonary disease: current burden and future projection. Eur Respir J. 2006; 27: 397–412.
4. Semik-Orzech A, Pierzchała W. Mechanizmy molekularne zapalenia w przewlekłej obturacyjnej chorobie płuc. Pneumonol Alergol Pol. 2009; 77: 66–71.
5. Eduard W, Pearce N, Douwes J. Chronic Bronchitis, COPD, and Lung Function in Farmers: The Role of Biological Agents. Chest. 2009; 136(3): 716–725.
6. Cynowska B, Słomiński JM. Przewlekła obturacyjna choroba płuc (POChP) w codziennej praktyce lekarskiej. Family Med Prim Care Rev. 2007; 9(3): 715–720.
7. Jelusic D, Wittmann, M, Schuler M, Schultz K. How does regular exercise affect dyspnoe (TDI) and quality of life (CAT) of COPD-patients 1 year after an inpatient pulmonary rehabilitation (PR)? Eur Respir J. 2015; 46(59): 553.
8. Kulczycka L, Sysa-Jędrzejowska A, Robak E. Jakość życia chorych na układowy toczeń rumieniowaty ze szczególnym uwzględnieniem metodyki badań. Postepy Hig Med Dosw. 2007; 61: 472–477.
9. Voelker H, Nayeemuddin, M, Albert RK, Connett JE, Bailey WC, Casaburi R., Han MK. Short-Term Impact Of Frequency Of COPD Exacerbations On Quality Of Life. Critical Care 2015; 6: 7.
10. Śliwiński P, Górecka D, Jassem E, Pierzchała W. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczącerozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc. Pneumon Alergol Pol. 2014; 82(3), 227–263.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993; 118: 622–629.
12. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental component summary measures – a user’s manual. The Health Institute, Boston 1994.
13. Jones P, Qiirk F, Baveystock CA. A selfcomplete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. A Rev Resp Dis. 1992; 145: 1321–7.
14. Hesselink A, van der Windt DA, Penninx BW. What predict change in pulmonary function and quality of life in asthma or COPD? J Asthma. 2006; 43(7): 513–19.
15. Martin A, Rodriguez- Gonzalez Moro JM, Izquierdo, Gobartt E, de Lukas P. Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish study, Int J Chron Obstruct Pulmon Dis. 2008; 3(4): 683–92.
16. Blinderman C, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic pulmonary disease. J Pain Symptom Manage. 2009; 38(1): 115–23.
17. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999; 116(6): 1632–7.
18. Haave E, Hyland ME, Skumlien S. The relation between measures of health status and quality of life in COPD. Chron Respir Dis. 2006; 3(4): 195–9.
19. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The Saint George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145(6): 1321–7.
20. Engstorm C, Persson L, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be use. Eur Respir J. 2001; 18(1): 69–76.
21. de La Fuente CR, de La Iglesia MF, Ramos PV, Pellicer VC, Nicolás MR, Diz-Lois M F. Factor analysis of the health related quality of life of patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2001; 37(10): 411–6.
22. Punekar YS, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: a western view. Respir Mes. 2007; 101(3): 661–9.
23. Wijnhoven HA, Kriegsman DM, Hesselink AE, Penninx BW, de Haan M. Determinants of different dimensions of disease severity in asthma and Copd: pulmonary function and health-related quality of life. Chest. 2001; 119(4): 1034–42.
24. Ong KC, Lu SJ, Soh CS. Does the multidimentional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis. 2006; 1(1): 91–6.
25. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med. 1984; 144: 1613–9.
26. Pietras T, Witusik A, Panek M, Hołub M, Gałecki P, Wujcik R, Górski P. Lęk i depresja u chorych na choroby obturacyjne płuc. Pol Merkur Lek. 2009; 26: 631–635.
27. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010; 137: 341–347.
28. Potoczek A, Niżankowska-Mogilnicka E, Bochenek G, Szczeklik A. Związki pomiędzy zespołem lęku napadowego i depresją a mechanizmami obronnymi, koherencją i funkcjonowaniem rodzinnym u pacjentów z rozpoznaniem ciężkiej POCHP. Psychiatr Pol. 2008; 42(5): 731–748.
29. Gardener AC, Farquhar M, Butcher HH, Moore C, Ewing G, White P, Mendonca S. Higher service use amongst the patients with advanced COPD and psychological co-morbidities: Associations with quality of life, co-morbidities and exacerbations. Thorax. 2015; (70): 100–101.
30. Julian LJ, Gregorich SE, Earnest G, Eisner MD, Chen H, Blanc, PD, Katz PP. Screening for depression in chronic obstructive pulmonary disease. COPD. 2009; 6: 452–8.
31. Yohannes A, Baldwin R, Connoly M. Depression and anxiety in eldery patients with chronic obstructive pulmonary disease. Age Agening. 2006; 35: 457–459.
32. PRAC, RO, CZASOPISMA, LR. Związki pomiędzy zespołem lęku napadowego i depresją a mechanizmami obronnymi, koherencją i funkcjonowaniem rodzinnym pacjentów z rozpoznaniem ciężkiej POCHP. Psychiatria i Psychoterapia. 2015; 11(4): 731–748.
33. Talarowska M, Florkowski A, Gałecki P, Szemraj J, Zboralski, K, Pietras T, Górski P. The impact of psychological variables on the presentation and progress of asthma and patient’s cognitive functions. Pneumon Alergol Pol. 2009; 77(6): 554–559.
34. Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Revelance to major depression. AnNY Acad Sci. 2009; 1179: 86–105.
35. Pietras T, Witusik A, Panek M, Gałecki P, Szemraj J, Górski P. Lęk i depresja a polimorfizm genu kodującego dysmutazę ponadtlenkową u chorych na przewlekłą obturacyjną chorobę płuc. Pol Merk Lek. 2010; 29 (171): 165.
36. Potoczek A, Niżankowska-Moglnicka E, Bochenek G, Szczeklik A. Ciężka POCHP i płeć chorych a obecność doznanych urazów psychicznych. Psychiatr Pol. 2008; 5: 719–730.
37. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray N, Stanley M. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005; 127: 1205–1211.
38. Garrido PC, de Miguel Diez J, Gutierrez JR, Centeno AM, Vázquez EG, de Miguel ÁG, García RJ. Negative impact of chronic obstructive pulmonary disease on the health – related quality of life of patients. Results of the EPIDEPOC study, Health Qual Life Outcomes. 2006; 23: 4–31.
39. de La Fuente CR, de La Iglesia MF, Ramos PV, Pellicer V C, Nicolás MR, Diz-Lois MF. Factor analysis of the health related quality of life of patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2001; 37: 411–416.
40. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996; 51: 39–43.
41. Stahl E, Lindberg A, Jansson S, Rönmark E, Svensson K, Andersson F, Lundbäck B. Health related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2006; 23: 4–31.
42. Bąk-Drabik K, Ziora D. Wpływ statusu socjoekonomicznego na jakość życia chorych na przewlekłą obturacyjna chorobę płuc. Pneumon Alergol Pol. 2010; 78(1): 3–13.
43. Mody R., Smith MJ. Smoking status and health-related quality of life: as findings from the 2001. Am J Health Promot. 2006; 20(4): 251–8.
44. Orbon KH, Schermer TR, van der Gulden JW, Chavannes NH, Akkermans RP, Van Schayck OP, Folgering HT. Employment status and qualityof life in patients with chronic obstructive pulmonary disease. Int Arch Occup Environ Health. 2005; 78(6): 467–74.
45. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, Lundbäck B. Health related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005; 3(1): 1.
46. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996; 51: 39–4.
eISSN:1898-2263
ISSN:1232-1966